Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
-
Source:
Hematology, Transfusion and Cell Therapy. April 2022 44(2)
-
تفاصيل العنوان
-
Source:
Renal Failure. Nov2003, Vol. 25 Issue 6, p1029-1035. 7p. 3 Black and White Photographs.
تفاصيل العنوان
-
Authors :
Philippe ROUSSELOT, Clinical coordinator
-
Source:
OPEN LABEL PHASE 2 STUDY ON THE EFFICACY AND TOLERANCE OF A COMBINATION OF PONATINIB AND 5-AZACITIDINE IN CHRONIC MYELOGENOUS LEUKAEMIA IN ACCELERATED PHASE OR IN MYELOID
تفاصيل العنوان
-
Authors :
Annamaria Brioli, Principal Investigator
-
Source:
European CML Blast Crisis Register
تفاصيل العنوان
-
Source:
Hensley ML, van Hoomissen IC, Krahnke T, et al.: Imatinib in chronic myeloid leukemia (CML): outcomes in >7000 patients treated on expanded access program (EAP). [Abstract] Proceedings of the American
تفاصيل العنوان
-
Authors :
External Affairs
-
Source:
A Canadian Open-label, Multicenter, Expanded Access Study of Oral Nilotinib in Adult Patients With Imatinib-resistant or -Intolerant Chronic Myeloid Leukemia in Blast
تفاصيل العنوان
-
Authors :
Dr. Naeem A. Chaudhri, Principal Investigator
-
Source:
An Open-Label, Multicenter, Expanded Access Study of Oral AMN 107 in Adult Patients With Imatinib (Glivec®/Gleevec®_ - Resistant or Intolerant Chronic Myeloid Leukemia in
تفاصيل العنوان
-
Source:
An Open-label, Multicenter Study of Treatment With Nilotinib in Adult Patients With Imatinib - Resistant or - Intolerant Chronic Myeloid Leukemia in Blast
تفاصيل العنوان
-
Source:
An Open-label, Multicenter Study of Oral AMN107 (Nilotinib) in Adult Patients With Imatinib - Resistant or - Intolerant Chronic Myeloid Leukemia in Blast
تفاصيل العنوان